Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hsiung

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS familyAdam L Boxer, Ian R Mackenzie, Bradley F Boeve, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 24, 2025
Protocol for the Asian Cohort for Alzheimer's Disease (ACAD) StudyPei-Chuan Ho, Guerry M Peavy, Haeok Lee, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 17, 2019
The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort StudyHoward Chertkow, Michael Borrie, Victor Whitehead, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Network Open|October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic VariantsAdam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Neuron|September 28, 2011
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALSMariely DeJesus-Hernandez, Ian R Mackenzie, Bradley F Boeve, et al.
Neurobiology of Aging|May 29, 2014
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriersMarka van Blitterswijk, Bianca Mullen, Michael G Heckman, et al.
Neurology|July 5, 2022
Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar DegenerationPhilip Wade Tipton, Angela B Deutschlaender, Rodolfo Savica, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS familyAdam L Boxer, Ian R Mackenzie, Bradley F Boeve, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 24, 2025
Protocol for the Asian Cohort for Alzheimer's Disease (ACAD) StudyPei-Chuan Ho, Guerry M Peavy, Haeok Lee, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 17, 2019
The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort StudyHoward Chertkow, Michael Borrie, Victor Whitehead, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
JAMA Network Open|October 28, 2020
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic VariantsAdam M Staffaroni, Sheng-Yang M Goh, Yann Cobigo, et al.
Neuron|September 28, 2011
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALSMariely DeJesus-Hernandez, Ian R Mackenzie, Bradley F Boeve, et al.
Neurobiology of Aging|May 29, 2014
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriersMarka van Blitterswijk, Bianca Mullen, Michael G Heckman, et al.
Neurology|July 5, 2022
Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar DegenerationPhilip Wade Tipton, Angela B Deutschlaender, Rodolfo Savica, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Pageof 11